Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Irene Noguera is active.

Publication


Featured researches published by Irene Noguera.


Nature Biotechnology | 2003

High-throughput engineering of the mouse genome coupled withhigh-resolution expression analysis

David M. Valenzuela; Andrew J. Murphy; David Frendewey; Nicholas W. Gale; Aris N. Economides; Wojtek Auerbach; William Poueymirou; Niels C. Adams; Jose Rojas; Jason Yasenchak; Rostislav Chernomorsky; Marylene Boucher; Andrea L Elsasser; Lakeisha Esau; Jenny Zheng; Jennifer Griffiths; Xiaorong Wang; Hong Su; Yingzi Xue; Melissa G. Dominguez; Irene Noguera; Richard Torres; Lynn Macdonald; A. Francis Stewart; Thomas M. DeChiara; George D. Yancopoulos

One of the most effective approaches for determining gene function involves engineering mice with mutations or deletions in endogenous genes of interest. Historically, this approach has been limited by the difficulty and time required to generate such mice. We describe the development of a high-throughput and largely automated process, termed VelociGene, that uses targeting vectors based on bacterial artificial chromosomes (BACs). VelociGene permits genetic alteration with nucleotide precision, is not limited by the size of desired deletions, does not depend on isogenicity or on positive–negative selection, and can precisely replace the gene of interest with a reporter that allows for high-resolution localization of target-gene expression. We describe custom genetic alterations for hundreds of genes, corresponding to about 0.5–1.0% of the entire genome. We also provide dozens of informative expression patterns involving cells in the nervous system, immune system, vasculature, skeleton, fat and other tissues.*Note: In the author list of the AOP version of this article, the name of author Rostislav Chernomorsky was misspelled Rostislav Chernomorski. This has been corrected in the online and print versions of the article.


Proceedings of the National Academy of Sciences of the United States of America | 2004

Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development

Nicholas W. Gale; Melissa G. Dominguez; Irene Noguera; Li Pan; Virginia A. Hughes; David M. Valenzuela; Andrew J. Murphy; Niels C. Adams; Hsin Chieh Lin; Jocelyn Holash; Gavin Thurston; George D. Yancopoulos


Archive | 2006

Therapeutic methods for inhibiting tumor growth with DII4 antagonists

Irene Noguera; Gavin Thurston; Nicholas W. Gale; Eric Smith


Archive | 2005

DII4 antagonists, assays, and therapeutic methods thereof

Gavin Thurston; Nicholas W. Gale; Irene Noguera


Archive | 2006

THERAPEUTIC USE OF A Dll4 ANTAGONIST AND A VEGF INHIBITOR FOR INHIBITING TUMOR GROWTH

Irene Noguera; Gavin Thurston; Nicholas W. Gale; Eric Smith


Archive | 2006

Procedes therapeutiques pour l'inhibition de croissance tumorale avec des antagonistes dll4

Irene Noguera; Gavin Thurston; Nicholas Gale; Eric Smith


Archive | 2006

therapeutic use of Dll4 antagonist and an inhibitor of VEGF to inhibit tumor growth

Irene Noguera; Gavin Thurston; Nicholas Gale; Eric Smith


Archive | 2006

Therapeutische verfahren zur hemmung von tumorwachstum mit dll4-antagonisten

Irene Noguera; Gavin Thurston; Nicholas Gale; Eric Smith


Archive | 2006

Uso terapéutico de un antagonista de DII4 y un inhibidor de VEGF para inhibir el crecimiento tumoral

Irene Noguera; Gavin Thurston; Nicholas W. Gale; Eric Smith


Archive | 2006

TERAPEUTISK ANVENDELSE AF EN Dll4-ANTAGONIST OG EN VEGF-HÆMMER TIL HÆMNING AF TUMORVÆKST

Irene Noguera; Gavin Thurston; Nicholas Gale; Eric Smith

Collaboration


Dive into the Irene Noguera's collaboration.

Researchain Logo
Decentralizing Knowledge